164 related articles for article (PubMed ID: 27609166)
1. Clinical outcome and regression patterns of retinoblastoma treated with systemic chemoreduction and focal therapy: A prospective study.
Chawla B; Jain A; Seth R; Azad R; Mohan VK; Pushker N; Ghose S
Indian J Ophthalmol; 2016 Jul; 64(7):524-9. PubMed ID: 27609166
[TBL] [Abstract][Full Text] [Related]
2. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
Shields CL; Mashayekhi A; Cater J; Shelil A; Ness S; Meadows AT; Shields JA
Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977
[TBL] [Abstract][Full Text] [Related]
3. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
[TBL] [Abstract][Full Text] [Related]
4. [Retinoblastoma regression patterns and results following chemo reduction and adjuvant therapy].
Xue K; Qian J; Yue H; Yuan YF; Zhang R
Zhonghua Yan Ke Za Zhi; 2012 Jul; 48(7):625-30. PubMed ID: 22943868
[TBL] [Abstract][Full Text] [Related]
5. Regression patterns in treated retinoblastoma with chemotherapy plus focal adjuvant therapy.
Ghassemi F; Rahmanikhah E; Roohipoor R; Karkhaneh R; Faegh A
Pediatr Blood Cancer; 2013 Apr; 60(4):599-604. PubMed ID: 23034769
[TBL] [Abstract][Full Text] [Related]
6. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors.
Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA
Trans Am Ophthalmol Soc; 2004; 102():35-44; discussion 44-5. PubMed ID: 15747743
[TBL] [Abstract][Full Text] [Related]
7. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
[TBL] [Abstract][Full Text] [Related]
8. Retinoblastoma regression patterns following chemoreduction and adjuvant therapy in 557 tumors.
Shields CL; Palamar M; Sharma P; Ramasubramanian A; Leahey A; Meadows AT; Shields JA
Arch Ophthalmol; 2009 Mar; 127(3):282-90. PubMed ID: 19273791
[TBL] [Abstract][Full Text] [Related]
9. Thermotherapy for retinoblastoma.
Shields CL; Santos MC; Diniz W; Gündüz K; Mercado G; Cater JR; Shields JA
Arch Ophthalmol; 1999 Jul; 117(7):885-93. PubMed ID: 10408452
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy and prognostic factors of chemoreduction combined with topical treatment for advanced intraocular retinoblastoma.
Liu Y; Zhang X; Liu F; Wang KL
Asian Pac J Cancer Prev; 2014; 15(18):7805-9. PubMed ID: 25292067
[TBL] [Abstract][Full Text] [Related]
11. [Clinical therapeutic efficiency of chemoreduction and local therapy for children with retinoblastoma].
Qian J; Xue K; Gao YJ; Yuan YF; Shan HD; Bi YW
Zhonghua Yan Ke Za Zhi; 2010 Apr; 46(4):312-6. PubMed ID: 20654057
[TBL] [Abstract][Full Text] [Related]
12. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
Brichard B; De Bruycker JJ; De Potter P; Neven B; Vermylen C; Cornu G
Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802
[TBL] [Abstract][Full Text] [Related]
13. Eye-preserving therapy in retinoblastoma: prolonged primary chemotherapy alone or combined with local therapy.
Shin JY; Kim JH; Yu YS; Khwarg SI; Choung HK; Shin HY; Ahn HS
Korean J Ophthalmol; 2010 Aug; 24(4):219-24. PubMed ID: 20714385
[TBL] [Abstract][Full Text] [Related]
14. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
Shields CL; Honavar SG; Shields JA; Demirci H; Meadows AT; Naduvilath TJ
Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors for Tumor Recurrence Following Primary Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma in 869 Eyes of 551 Patients.
Dalvin LA; Bas Z; Tadepalli S; Rao R; Vaidya S; Pacheco R; Shields CL
J Pediatr Ophthalmol Strabismus; 2020 Jul; 57(4):224-234. PubMed ID: 32687206
[TBL] [Abstract][Full Text] [Related]
16. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients.
Shields CL; Shelil A; Cater J; Meadows AT; Shields JA
Arch Ophthalmol; 2003 Nov; 121(11):1571-6. PubMed ID: 14609913
[TBL] [Abstract][Full Text] [Related]
17. Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors.
Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA
Am J Ophthalmol; 2004 Sep; 138(3):329-37. PubMed ID: 15364213
[TBL] [Abstract][Full Text] [Related]
18. [Diode laser thermotherapy and chemothermotherapy in the treatment of retinoblastoma].
Lumbroso L; Doz F; Levy C; Dendale R; Vedrenne J; Bours D; Zucker JM; Asselain B; Desjardins L
J Fr Ophtalmol; 2003 Feb; 26(2):154-9. PubMed ID: 12660589
[TBL] [Abstract][Full Text] [Related]
19. Transpupillary thermotherapy as initial treatment for small intraocular retinoblastoma: technique and predictors of success.
Abramson DH; Schefler AC
Ophthalmology; 2004 May; 111(5):984-91. PubMed ID: 15121378
[TBL] [Abstract][Full Text] [Related]
20. Indocyanine green enhanced transpupillary thermotherapy in combination with ophthalmic artery chemosurgery for retinoblastoma.
Francis JH; Abramson DH; Brodie SE; Marr BP
Br J Ophthalmol; 2013 Feb; 97(2):164-8. PubMed ID: 23143908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
